Atlas Trials

Carcinoid Tumors

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Carcinoid Tumors

RecordFirmDate
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (NCT02859064)SCRI Development Innovations, LLC2017-07-28
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors (NCT02795858)Dana-Farber Cancer Institute2016-06-14
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors (NCT02441062)Sue O'Dorisio2015-09-01
68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs) (NCT02359500)Lale Kostakoglu2014-12-01
GA-68 DOTA-TOC of Somatostatin Positive Malignancies (NCT02177773)University of California, San Francisco2014-06-23
A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors (NCT01731925)GERCOR - Multidisciplinary Oncology Cooperative Group2013-01-07
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors (NCT01619865)Sue O'Dorisio2012-02-21
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors (NCT00947167)Pamela L. Kunz2009-03-01
Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion (NCT00227136)University of Western Ontario, Canada2005-05-01
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors (NCT01373736)Vancouver Coastal Health
68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors (NCT01980732)Andrei Iagaru

Track Carcinoid Tumors automatically

Every clearance here is in the API, with alerts when new ones post.